In patients with osteosarcoma and in preclinical models of hepatocellular carcinoma cell lines, a correlation between the expression of CRM1 and cancer proliferation was demonstrated (Yao et al. 2009; Zheng et al. 2014). This evidence concerns the gene XPO1 and hepatocellular carcinoma.